The 17th Cancer Crosslinks
Presented: Thursday, January 23, 2025.
Streamed from Oslo Cancer Cluster Innovation Park.
Presented: Thursday, January 23, 2025.
Streamed from Oslo Cancer Cluster Innovation Park.
Cancer Crosslinks 2025 Presentations
Revolutionizing Cancer Therapy:
Breaking Barriers in Oncology with Tumor-Agnostic Drug Development
Vivek Subbiah, MD, Chief, Early-Phase Drug Development,
Sarah Cannon Research Institute (SCRI), Nashville, USA
Breaking Barriers in Oncology with Tumor-Agnostic Drug Development
Vivek Subbiah, MD, Chief, Early-Phase Drug Development,
Sarah Cannon Research Institute (SCRI), Nashville, USA
Can precision medicine deliver histology-independent drug discovery?
Ruth Plummer, Clinical Professor of Experimental Cancer Medicine,
Translational and Clinical Research Institute, Newcastle University Centre for Cancer,
Director of Sir Bobby Robson Cancer Trials Research Centre, Newcastle, UK
Ruth Plummer, Clinical Professor of Experimental Cancer Medicine,
Translational and Clinical Research Institute, Newcastle University Centre for Cancer,
Director of Sir Bobby Robson Cancer Trials Research Centre, Newcastle, UK
Arming CAR-T cells for potent bystander immune response in lymphoma and glioblastoma
Magnus Essand, Professor of Gene Therapy, Uppsala University, Department of Immunology,
Genetics and Pathology, Uppsala, Sweden
Magnus Essand, Professor of Gene Therapy, Uppsala University, Department of Immunology,
Genetics and Pathology, Uppsala, Sweden
Prime time for adoptive T-cell therapy for metastatic melanoma
Inge Marie Svane, Professor, MD, Director, National Center for Cancer Immune Therapy – CCIT-DK, Department of Oncology, Herlev Hospital, Copenhagen University, Denmark
Inge Marie Svane, Professor, MD, Director, National Center for Cancer Immune Therapy – CCIT-DK, Department of Oncology, Herlev Hospital, Copenhagen University, Denmark
From diagnosis to recovery, how digital innovations are transforming the cancer patient journey
Ingrid Stenstadvold Ross, Secretary General, Norwegian Cancer Society
Ingrid Stenstadvold Ross, Secretary General, Norwegian Cancer Society
AIDA - A national collaboration arena for clinical innovation in medical imaging diagnostics AI
Joel Hedlund, PhD, Data Director Center for Medical Image Science and Visualization (CMIV)/Analytic Imaging Diagnostics Arena (AIDA), AIDA Data Hub Lead, Linköping University, Sweden
Joel Hedlund, PhD, Data Director Center for Medical Image Science and Visualization (CMIV)/Analytic Imaging Diagnostics Arena (AIDA), AIDA Data Hub Lead, Linköping University, Sweden
Panel Discussion with all speakers
|
Organizer
|
Sponsors 2025
|
|
|
|
To learn more about previous Cancer Crosslinks events, visit the GALLERY.